Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
높은 배당금
회사는 높은 배당금을 지급하는 회사로, 최신 배당금 지급 비율은 20.13%입니다.
안정적인 배당금
회사는 지난 5년 동안 정기적으로 배당금을 지급하였으며, 최신 배당금 지급 비율은 20.13%입니다.
과소 평가된
회사의 최신 PE은 34.32로, 최근 3년 기준 낮은 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 594.48M주이며, 전 분기 대비 0.66% 감소했습니다.
앨 고어가 보유
스타 투자자 앨 고어이(가) 이 주식 7.97M주를 보유하고 있습니다.